rs144686314

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_144670.6(A2ML1):​c.3676_3677delGC​(p.Ala1226GlnfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0475 in 1,613,182 control chromosomes in the GnomAD database, including 2,054 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1226A) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.036 ( 134 hom., cov: 33)
Exomes 𝑓: 0.049 ( 1920 hom. )

Consequence

A2ML1
NM_144670.6 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: 1.20

Publications

11 publications found
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
A2ML1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 12-8863966-GGC-G is Benign according to our data. Variant chr12-8863966-GGC-G is described in ClinVar as Benign. ClinVar VariationId is 413822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0575 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A2ML1NM_144670.6 linkc.3676_3677delGC p.Ala1226GlnfsTer34 frameshift_variant Exon 29 of 36 ENST00000299698.12 NP_653271.3 B3KVV6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A2ML1ENST00000299698.12 linkc.3676_3677delGC p.Ala1226GlnfsTer34 frameshift_variant Exon 29 of 36 1 NM_144670.6 ENSP00000299698.7 A8K2U0-1
A2ML1ENST00000541459.5 linkc.2326_2327delGC p.Ala776GlnfsTer34 frameshift_variant Exon 18 of 25 2 ENSP00000443174.1 H0YGG5
A2ML1ENST00000539547.5 linkc.2203_2204delGC p.Ala735GlnfsTer34 frameshift_variant Exon 18 of 25 2 ENSP00000438292.1 A8K2U0-2
ENSG00000282022ENST00000631830.1 linkn.322-5692_322-5691delGC intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0359
AC:
5470
AN:
152158
Hom.:
134
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0106
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0359
Gnomad ASJ
AF:
0.0620
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.0626
Gnomad FIN
AF:
0.0302
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0514
Gnomad OTH
AF:
0.0455
GnomAD2 exomes
AF:
0.0432
AC:
10760
AN:
249188
AF XY:
0.0459
show subpopulations
Gnomad AFR exome
AF:
0.00936
Gnomad AMR exome
AF:
0.0285
Gnomad ASJ exome
AF:
0.0635
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.0310
Gnomad NFE exome
AF:
0.0525
Gnomad OTH exome
AF:
0.0513
GnomAD4 exome
AF:
0.0487
AC:
71145
AN:
1460906
Hom.:
1920
AF XY:
0.0496
AC XY:
36049
AN XY:
726772
show subpopulations
African (AFR)
AF:
0.00921
AC:
308
AN:
33456
American (AMR)
AF:
0.0293
AC:
1309
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0624
AC:
1631
AN:
26132
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0687
AC:
5921
AN:
86186
European-Finnish (FIN)
AF:
0.0317
AC:
1695
AN:
53398
Middle Eastern (MID)
AF:
0.0846
AC:
432
AN:
5106
European-Non Finnish (NFE)
AF:
0.0513
AC:
57032
AN:
1111914
Other (OTH)
AF:
0.0466
AC:
2812
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3136
6272
9407
12543
15679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2094
4188
6282
8376
10470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0359
AC:
5468
AN:
152276
Hom.:
134
Cov.:
33
AF XY:
0.0351
AC XY:
2617
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0106
AC:
441
AN:
41556
American (AMR)
AF:
0.0358
AC:
547
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0620
AC:
215
AN:
3468
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5178
South Asian (SAS)
AF:
0.0633
AC:
305
AN:
4818
European-Finnish (FIN)
AF:
0.0302
AC:
320
AN:
10612
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0514
AC:
3495
AN:
68026
Other (OTH)
AF:
0.0450
AC:
95
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
267
534
800
1067
1334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0458
Hom.:
33
Bravo
AF:
0.0346
Asia WGS
AF:
0.0220
AC:
76
AN:
3478
EpiCase
AF:
0.0537
EpiControl
AF:
0.0567

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24896146) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otitis media Uncertain:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Aug 12, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: A2ML1 c.3676_3677delGC (p.Ala1226GlnfsX34) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay. However, the variant allele was found at a frequency of 0.043 in 249188 control chromosomes, predominantly at a frequency of 0.068 within the South Asian subpopulation in the gnomAD database, including 87 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 17000-folds over the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. Two ClinVar submissions (evaluation after 2014) cite the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=157/43
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144686314; hg19: chr12-9016562; COSMIC: COSV55288502; COSMIC: COSV55288502; API